Novartis and Voyager, JPM Ahead, Epigenetic Engineering; Alex Aravanis
About this episode
Episode 3 (January 5, 2024): Interview with Co-founder and CEO of Moonwalk Biosciences and former CTO of Illumina, Alex Aravanis; Neuro gene therapy with Novartis and Voyager; GEN reporters look forward to the 2024 J.P. Morgan Healthcare Conference
Listed below are key references to the GEN stories, media and other items discussed in this episode of Touching Base:
By Alex Philippidis, GEN, January 2, 2024.
By Uduak Thomas, GEN, January 4, 2024.
Hosted on Acast. See acast.com/privacy for more information.
Get every episode summarized
Each time Touching Base publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Touching Base
BMS’s New Facility, Recursion–Genentech Partnership, Long-COVID and Persistent C...
Touching Base
Axiom’s Hong Kong Bet, Latigo’s Positive Phase II, and Base Editors for Huntingt...
Touching Base
Parkinson’s in the Clinic, Insilico enters Phase III, Vertex Acquires Crinetics
Touching Base
Merck and Insilico Make Deals, Claude Science’s Debut, Vaccines for Neglected Di...
Touching Base